Common examples include semaglutide (Ozempic), dulaglutide (Trulicity), and exenatide (Byetta), the first GLP-1 drug approved back in 2005
Medically Unsuitable Alternatives: There must be a clinical reason why an existing FDA-approved drug cannot be used for certain patients
Obstructive sleep apnea and testosterone deficiency
Another study reported that the bitter taste of berberine causes the activation of bitter taste receptors (TAS2Rs), which further activates the downstream signalling pathway, leading to enhanced GLP-1 secretion 4
In pain and addiction care, stop-start patterns are common when insurance coverage shifts or supply is disrupted
These medications are vital in treating type 2 diabetes by lowering after-meal blood sugar, supporting weight loss, and helping to preserve insulin-producing cell function over time